Chromosome 9 aberrations by fluorescence in situ hybridisation in bladder transitional cell carcinoma

This publication has 21 references indexed in Scilit:

• Bladder transitional cell carcinomas: a comparative study of washing and tumor bioptic samples by DNA flow cytometry and FISH analyses.
  European Urology, 2000
• Markers for recurrence of superficial bladder cancer: what is valid?
  Current Opinion in Urology, 1999
• Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines
  British Journal of Cancer, 1999
• Fortnightly review: Bladder cancer
  BMJ, 1998
• PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE
  Published by Wolters Kluwer Health ,1998
• Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder
  International Journal of Cancer, 1998
• LOSS OF CHROMOSOME 9 IN TISSUE SECTIONS OF TRANSITIONAL CELL CARCINOMAS AS DETECTED BY INTERPHASE CYTOGENETICS. A COMPARISON WITH RFLP ANALYSIS
  The Journal of Pathology, 1996
• Chromosome‐9 loss detected by fluorescence in situ hybridization in bladder cancer
  International Journal of Cancer, 1995
• Concordance between karyotyping and in situ hybridization procedures in the detection of monosomy 9 in bladder cancer
  Cancer Genetics and Cytogenetics, 1993
• Bladder cancer.Advances in laboratory innovations and clinical management, with emphasis on innovations allowing bladder-sparing approaches for patients with invasive tumors
  Cancer, 1990